Sessioni Poster

Pharmacovigilance

Mercoledì 28 Ottobre 2015 / 19.00-20.00
16Sertraline and extrapyramidal effects: an unknown case of dysgraphia
Gentili M., Galimberti C., Fusi O., Carnovale C., Marinaccio P., Ba G., Clementi E., Radice S., Viganò C.
20Drug induced progressive multifocal leukoencephalopathy: a comprehensive analysis of the WHO adverse drug reactions database
Melis M., Biagi C., Småbrekke L., Nonino F., Buccellato E., Donati M., Vaccheri A., Motola D.
32Safety profile of H1-antihistamines in children: an analysis based on data from VigiBase
Biagi C., Donati M., Melis M., Calamelli E., Monaco L., Ricci G., Vaccheri A., Motola D.
40Adverse Drug Reactions, Medication Adherence and Physicians’ Prescribing Behavior: Which relationship? A Database Analysis on Statin Use
Leporini C., Degli Esposti L., Sangiorgi D., Ursini F., Scicchitano F., De Sarro G., Russo E.
59Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy
Cimmaruta D., Sullo MG., Perri D., Sibilio M., Rafaniello C., Fucile A., Rossi F., Capuano A.
139A simple informative intervention in primary care increases statin adherence
Casula M., Tragni E., Piccinelli R., Zambon A., De Fendi L., Scotti L., Corrao G., Gambera M., Catapano AL.
216Comparative safety of antiplatelet agents: a study of “real-world” data from the Italian National Pharmacovigilance Network
Gozzo L., Navarria A., Drago V., Longo L., Mansueto S., Pimpinella G., Pani L., Drago F.
238Adverse drug reactions caused by ketorolac off-label use in Italy
Viola E., Trifirò G., Sottosanti L., Ingrasciotta Y., Tari M., Gonella LA., Giorgianni F., Lora R., Leone R., Conforti A.
243Biosimilars-induced Adverse Drug Reactions. Analysis of the Italian Pharmacovigilance Database
Stoppa G., Opri S., Sottosanti L., Moretti U., Pagliarini M., Conforti A.
249Detection and analysis of medication errors in the Italian Pharmacovigilance Database
Magro L., Arzenton E., Viola E., Lora R., Sottosanti L., Capuano A., Sportiello L., Rossi F., Leone R.
253Drug interactions with lithium: long known but still overlooked. An emblematic case.
Baggiani G., Chillotti C., Capra C., Bocchetta A.
255Elevation of Clozapine Serum Concentrations: Probable Interaction with Omeprazole
Traccis F., Deidda A., Stochino ME., Martinelli V., Squassina A., Congiu D., Bocchetta A.
314Notification of Undesirable Effects and Serious Undesirable Effects to the Italian Ministry of Health according to the Regulation (EC) No. 1223/2009 on cosmetic products (“Cosmetics Regulation”): a two year survey
Caputo I., Fabbri E., D'Alessandro P., Sautebin L., Marletta M.
316Interstitial lung disease induced by fluoxetine
Deidda A., Lampus S., Bocchetta A., Pisanu C., Micheletto L., Sanna MV., Stochino ME.
325Adverse Reactions to Vaccines Causing Children Admission to the Paediatric Emergency Department: a Single Center Study

Mecchio AM., Arcoraci V., Mennito F., Minutoli L., Cutroneo PM., Arrigo T., Altavilla D.
340Agreement between potential drug interactions identified by an electronic tool and clinical judgment: INTERCheck® versus physicians

Antoniazzi S., Chiarelli MT., Venturini F., Nobili A., Pasina L., Casiraghi C., Santalucia P., Marcucci M., Damanti S., Periti G., Porzio M., Rossio R., Peyvandi F., Fargion S., Mari D., Monzani V., Mannucci PM.
343Pharmacovigilance active project: biological drugs use in the Policlinico Hospital of the Second University of Naples
Fiorentino S., Auricchio F., Bernardi FF., Bonagura AC., Cenami R., Cimmaruta D., Ferrajolo C., Formica R., Limone L., Maccariello A., Mascolo A., Perone I., Rafaniello C., Sessa M., Scavone C., Sportiello L., Sullo MG., Rossi F., Capuano A., Dello Iacono D.
371Paediatric Drug Safety Surveillance in Italian Pharmacovigilance Network: an overview of Adverse Drug Reactions in the years 2001-2012
Ferrajolo C., Capuano A., Rossi F., Moretti U., Trifirò G., Santuccio C.
379Forward (Facilitation Of Reporting in hospital WARD) project: an useful tool to improve the detection, evaluation and reporting of ADRs in hospital setting
Macrì R., Sirna V., Giardina C., Anfuso Alberghina M., Tarro P., Garaffo E., Ferrara R., Cutroneo PM., Arcoraci V.
411Multi-medication in an Italian Neonatal Intensive Care Unit: focus on drugs with nephrotoxic potential
Girardi A., Raschi E., Poluzzi E., Lorenz M., Galletti S., Faldella G., De Ponti F.
421No neuromuscular block after maximal dose of rocuronium: a case report
Maccariello A., Auricchio F., Bernardi F F., Bonagura A C., Cenami R., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Limone L., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo M G., Capuano A., Rossi F.
449Pharmacovigilance in oncology: analysis of adverse drug reaction in the last three years
Nappi A., Bonagura AC., Spatarella M., Zuppardi P.
456Oncological drug-related adverse events reported in the 'FARMAONCO' database in 2014 at the I.R.C.C.S. San Matteo University Hospital in Pavia
Ferrari A., Porta C., Giglione P., Ferraris E., Delfanti S., Paglino C., Perfetti V., Lombardo F., Brugnatelli S., Secondino S., Valentino F., Pagani A., Grasso D., Reversi F., Morabito S., Mariucci S., Imarisio I., Guarnone E., Pedrazzoli P., Calvi M.
503Desirable (possible?) Sustainable Development of Italian Pharmacovigilance System
Cosentino E., Peru M.
506A brief overview of pharmacovigilance in the Molise Region: toward a long-awaited change of pace

Ambrosino P., Lavalle A., Rea R., Di Lizia B., Soldovieri MV., Russo C., Taglialatela M.
527QT interval prolongation and hydroxyzine: a retrospective cohort analysis on hospitalized elderly patients
Montagnani S., Blandizzi C., Marino A., Pasqualetti G., Qasem A., Cottone S., Capogrosso-Sansone A., Mantarro S., Convertino I., Saporiti A., Salvadori S., Fornai M., Antonioli L., Monzani F., Tuccori M.
531Estimation of theoretical cost preventability achievable with an effective pharmacovigilance activity in a Pharmacovigilance Regional Centre in Italy
Convertino I., Capogrosso-Sansone A., Mantarro S., Montagnani S., Marino A., Saporiti A., Blandizzi C., Tuccori M.
542Potential and actual drug-drug interactions in elderly patients admitted to an emergency department: data from the ANCESTRAL-ED study
Convertino I., Capogrosso-Sansone A., Marino A., Tuccori M., Mantarro S., Montagnani S., Saporiti A., Bini G., Sieli R., Pasqualetti G., Monzani F., Santini M., Blandizzi C.
576Active surveillance on the pediatric antibiotic use in the age group between 0 and 2 years
Lavalle A., Rea R., Ambrosino P., di Lizia B., Russo C., Taglialatela M.
587Severe cardiac events following treatment with trastuzumab in women with breast cancer: a meta-analysis of clinical trials and cohort studies
Mantarro S., Rossi M., Tuccori M., Capogrosso-Sansone A., Convertino I., Montagnani S., Marino A., Saporiti A., Garibaldi D., D'Amico R., Negri E., La Vecchia C., Moja L., Blandizzi C.
593Evaluation of reporting risk for myopathy using the Italian Adverse Drug Reaction Spontaneous Reporting Database: proton pump inhibitors and their interaction with statins
Capogrosso-Sansone A., Galiulo MT., Tuccori M., Mantarro S., Montagnani S., Convertino I., Marino A., Saporiti A., Salvadori S., Fornai M., Antonioli L., Renda F., Blandizzi C.
657PHYTO.VIG.GEST: “Vigilance on use of drugs, herbal products and food supplements during pregnancy”. Preliminar results
Mannucci C., Dante G., Miroddi M., Facchinetti F., D'Anna R., Santamaria A., Calapai F., Lenti MC., Vannacci A., Perone M., Navarra M., Calapai G.
67Safety of Antipsychotic Drugs in Paediatric patients
Limone L., Auricchio F., Bernardi FF., Bonagura AC., Cenami R., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Maccariello A., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo MG., Capuano A.
368Healthcare databases for paediatric studies: a report from the GRiP network global survey
Ferrajolo C., Osokogu O., Brauchli Pernus Y., Weibel D., Verhamme KMC., Gazarian M., Wong ICK., Nakamura H., Bonhoeffer J., Giaquinto C., Sturkenboom MCJM.
732The effects of the β-cyclodextrin, as a solubility enhancer, on the efficacy and safety of diclofenac and progesterone formulations
Scavone C., Bonagura AC., Fiorentino S., Cenami R., Tortella M., Fossati T., Rossi F.
733Kounis syndrome: an analysis of spontaneous reports from international pharmacovigilance database
Renda F., Landoni G., Trotta F., Piras D., Finco G., Felicetti P., Pimpinella G., Pani L.
349The activities of the Ethics Committee of Lecce following the reorganization of the Committees Ethics: Law Balduzzi (189/12) and D.M. 02/08/2013
Romano R., Canitano M., Morciano C., Conte D., Comitato .
267Monitoring of Adverse Events in Paediatrics (MEAP) Project: preliminary results
Cenami R., Auricchio F., Bernardi FF., Bonagura AC., Cimmaruta D., Ferrajolo C., Fiorentino S., Formica R., Limone L., Maccariello A., Mascolo A., Perone I., Rafaniello C., Scavone C., Sessa M., Sportiello L., Sullo MG., Rossi F., Capuano A.